PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

被引:0
|
作者
N Rökaeus
J Shen
I Eckhardt
V J N Bykov
K G Wiman
M T Wilhelm
机构
[1] Cancer Center Karolinska (CCK),Department of Oncology
[2] Karolinska Institutet,Pathology
[3] Tumor and Cell Biology (MTC),Department of Microbiology
[4] Karolinska Institutet,undefined
来源
Oncogene | 2010年 / 29卷
关键词
PRIMA-1; APR-246; reactivation; mutant p63; mutant p73; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
The low molecular weight compound PRIMA-1 and the structural analog PRIMA-1MET, also named APR-246, reactivate mutant p53 through covalent binding to the core domain and induce apoptosis in tumor cells. Here, we asked whether PRIMA-1MET/APR-246 can rescue mutant forms of the p53 family members p63 and p73 that share high sequence homology with p53. We found that PRIMA-1MET/APR-246 can restore the pro-apoptotic function to mutant TAp63γ and TAp73β in tumor cells but has less effect on TAp73α. Moreover, PRIMA-1MET/APR-246-stimulated DNA binding of mutant TAp63γ and induced expression of the p53/p63/p73 downstream targets p21 and Noxa. The reactivation of mutant p53, p63 and p73 by PRIMA-1MET/APR-246 indicates a common mechanism, presumably involving homologous structural elements in the p53 family proteins. Our findings may open avenues for therapeutic intervention in human developmental disorders with mutations in p63.
引用
收藏
页码:6442 / 6451
页数:9
相关论文
共 50 条
  • [1] PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
    Rokaeus, N.
    Shen, J.
    Eckhardt, I.
    Bykov, V. J. N.
    Wiman, K. G.
    Wilhelm, M. T.
    ONCOGENE, 2010, 29 (49) : 6442 - 6451
  • [2] Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
    Aryee, D. N. T.
    Niedan, S.
    Ban, J.
    Schwentner, R.
    Muehlbacher, K.
    Kauer, M.
    Kofler, R.
    Kovar, H.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2696 - 2704
  • [3] Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
    D N T Aryee
    S Niedan
    J Ban
    R Schwentner
    K Muehlbacher
    M Kauer
    R Kofler
    H Kovar
    British Journal of Cancer, 2013, 109 : 2696 - 2704
  • [4] PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
    Saha, Manujendra N.
    Jiang, Hua
    Yang, Yijun
    Reece, Donna
    Chang, Hong
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) : 2331 - 2341
  • [5] p63 and p73, members of the p53 gene family, transactivate PKCδ
    Ponassi, Raffaella
    Terrinoni, Alessandro
    Chikh, Anissa
    Rufini, Alessandro
    Lena, Anna Maria
    Sayan, Berna S.
    Melino, Gerry
    Candi, Eleonora
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1417 - 1422
  • [6] P53, p63 and p73 - solos, alliances and feuds among family members
    Moll, UM
    Erster, S
    Zaika, A
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1552 (02): : 47 - 59
  • [7] Role of p53 family members p73 and p63 in human hematological malignancies
    Alexandrova, Evguenia M.
    Moll, Ute M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2116 - 2129
  • [8] PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
    Zandi, Roza
    Selivanova, Galina
    Christensen, Camilla Laulund
    Gerds, Thomas Alexander
    Willumsen, Berthe Marie
    Poulsen, Hans Skovgaard
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2830 - 2841
  • [9] p63 and p73, the Ancestors of p53
    Doetsch, V.
    Bernassola, F.
    Coutandin, D.
    Candi, E.
    Melino, G.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (09): : a004887
  • [10] From p53 to p63 and p73
    不详
    TRENDS IN GENETICS, 1999, 15 (06) : 222 - 222